Actionable news
0
All posts from Actionable news
Actionable news in PBYI: PUMA BIOTECHNOLOGY INC,

Puma Biotech Is up 181% This Year; Here’s Why It Can Still Go Higher

Puma Biotechnology (PBYI) is up more than 181% since the start of the year, but that doesn't mean that the rally is over, argues Leerink.

Analyst Michael Schmidt resumed coverage of the stock with an Outperform rating and $115 price target on Monday. He argues that there's more room for the stock to run, given that it still trades at a significant discount to its oncology biotech peers.

There's some logic to...


More